XTL Biopharmaceuticals acquires 85% stake in NeuroNOS for autism therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| (NASDAQ: XAIR) | Delayed: 2.84 +0.02 (0.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.82 | 52 Week High | $ | |||
| Open | $2.93 | 52 Week Low | $ | |||
| Day High | $2.99 | P/E | N/A | |||
| Day Low | $2.81 | EPS | $ | |||
| Volume | 43,087 | |||||
| XTL BIOPHARM SP ADR (NASDAQ: XTLB) | Delayed: 2.18 +0.02 (0.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.16 | 52 Week High | $1.75 | |||
| Open | $2.20 | 52 Week Low | $0.64 | |||
| Day High | $2.36 | P/E | N/A | |||
| Day Low | $2.17 | EPS | $0.00 | |||
| Volume | 12,935 | |||||
